Published in Vestn Oftalmol on December 17, 1983
Value of fluorescein iridography in diagnosis of tumours of the iridociliary zone. Br J Ophthalmol (1979) 0.90
[Fluorescence aniography in diagnosis of tumors of the iridociliary zone]. Vestn Oftalmol (1977) 0.83
Ciliochoroidal melanomas treated with a narrow medical proton beam. Arch Ophthalmol (1986) 0.82
[Interferon status of patients with uveal melanoma]. Vestn Oftalmol (2000) 0.75
[Oxygenation of glioblastomas and normal brain tissue during radiation therapy]. Med Radiol (Mosk) (1983) 0.75
[Methods and diagnostic value of tomophlebography in orbital neoplasms]. Vestn Oftalmol (1972) 0.75
[Scanning of primary and secondary orbital neoplasms with Se75-methionine]. Vestn Oftalmol (1976) 0.75
[Choice of surgical method in orbital neoplasms]. Vestn Oftalmol (1972) 0.75
[Combined use of computed tomography and gamma-topography in orbital diseases]. Med Radiol (Mosk) (1988) 0.75
[Clinical and x-ray parallels in orbital tumors]. Oftalmol Zh (1973) 0.75
[Method of preventing ptosis and repositioning of the prolapsed vitreous body during intraocular operations]. Vestn Oftalmol (1984) 0.75
[Hemangioma of the choroid]. Oftalmol Zh (1985) 0.75
[Ultrasonic diagnosis of tumors of the orbit and of underlying diseases]. Oftalmol Zh (1972) 0.75
[Enucleation in the treatment of choroid melanoma]. Vestn Oftalmol (1984) 0.75
[Bilateral retinoblastoma]. Vestn Oftalmol (1994) 0.75
[Computed tomographic anatomy of the orbit in the view of a clinician]. Vestn Oftalmol (2008) 0.75
[Cryodestruction of choroidal melanomas]. Vestn Oftalmol (1977) 0.75
[The characteristics of the clinical picture of lymphosarcoma and of a metastatic tumor of the orbit of another origin]. Vestn Oftalmol (2000) 0.75
[Echobiometric studies in beta-application therapy of choroid tumors]. Vestn Oftalmol (1978) 0.75
[Clinical aspects of inflammatory diseases of the orbit of autoimmune origin]. Vestn Oftalmol (1992) 0.75
[Procedure for calculating the volume of the orbital fat to be removed at decompressive surgery in patients with endocrine ophthalmopathy]. Vestn Oftalmol (2009) 0.75
[Comparative assessment of methods of biomicroophthalmoscopy]. Vestn Oftalmol (1968) 0.75
[Blood circulation in the optic nerve disk in orbital tumors]. Vestn Oftalmol (1980) 0.75
[Metastatic involvement of liver in patients with uveal melanoma]. Vestn Oftalmol (1998) 0.75
[Risk factors and complications in orbital surgery, their preventive measures]. Vestn Oftalmol (2007) 0.75
[Reactive syndrome following laser coagulation of intraocular tumors and its prevention]. Vestn Oftalmol (1983) 0.75
[Live xenogenic vaccine in the prevention of metastases of uveal melanoma]. Vestn Oftalmol (2009) 0.75
[Organ-sparing treatment of uveal melanomas: safety borders]. Vestn Ross Akad Med Nauk (2007) 0.75
[Malignant (non-Hodgkin's) lymphoma of the organ of vision]. Vestn Oftalmol (2009) 0.75
[Treatment of epibulbar malignant neoformations with radioactive strontium applicators]. Oftalmol Zh (1977) 0.75
[Optimization of indications for transpupillary thermotherapy for choroidal melanomas]. Vestn Oftalmol (2010) 0.75
[Possibilities of orbital surgery: limits of its safety]. Vestn Oftalmol (1989) 0.75
[Intraocular malignant lymphoma]. Vestn Oftalmol (1991) 0.75
[Late results in treating uveal melanomas. A comparative evaluation of enucleation and organ-preserving treatment methods]. Oftalmol Zh (1989) 0.75
[Treatment of tumors of the eyelids and conjunctiva with low temperatures]. Vestn Oftalmol (1981) 0.75
[Prospects for radiotherapy of optic nerve meningioma]. Vestn Oftalmol (2003) 0.75
[RB1 and CDKN2A functional defects resulting in retinoblastoma]. Mol Biol (Mosk) (2002) 0.75
[Results of beta-therapy of choroidal melanoma]. Med Radiol (Mosk) (1980) 0.75
[Potentialities of computed tomography in the differential diagnosis of benign orbital tumors]. Vestn Oftalmol (1987) 0.75
[Classification of eye neoplasms]. Vestn Oftalmol (1974) 0.75
[Morphological changes in the retina after argon laser coagulation of choroid tumors]. Vestn Oftalmol (1988) 0.75
[State and tasks of ophthalmologic oncological services]. Vestn Oftalmol (1983) 0.75
[Lipogenic type of edematous exophthalmos: clinical picture, treatment]. Vestn Oftalmol (2008) 0.75
[Reasons for complications stemming from orbital surgery and measures to prevent them]. Vestn Oftalmol (1972) 0.75
[Computed tomographic signs of extraocular muscle changes in endocrine ophthalmopathy]. Vestn Oftalmol (2007) 0.75
[Metastatic tumors of the eye in breast cancer]. Vestn Oftalmol (1986) 0.75
[Rare vascular tumors of the orbit (hemangioendothelioma and hemangiopericytoma)]. Oftalmol Zh (1986) 0.75
[Experience in the advanced training of the professor-instructor staff]. Vestn Oftalmol (1968) 0.75
[Gamma-interferon in patients with uveal melanoma]. Vestn Oftalmol (2000) 0.75
[Treatment of retinoblastoma: modern concept]. Vestn Oftalmol (2005) 0.75
[Experience in the treatment of eye tumors using a narrow medical proton beam]. Med Radiol (Mosk) (1987) 0.75
[Temperature changes in the eye tissue during freezing]. Vestn Oftalmol (1980) 0.75
[Orbitography in the diagnosis of eye neoplasms]. Vestn Oftalmol (1970) 0.75
[Reasons for enucleations following the combined treatment of choroidal melanomas]. Vestn Oftalmol (1982) 0.75
[Current aspects of treatment for choroidal melanomas: problems, controversial questions]. Vestn Oftalmol (2006) 0.75
[Bilateral uveal melanomas]. Vestn Oftalmol (1984) 0.75
[The problems of endocrine ophthalmopathy]. Vestn Oftalmol (2008) 0.75
[Characteristics of small saccadic eye movements in endocrine myopathies]. Vestn Oftalmol (1984) 0.75
[Formalization of the process of differential diagnosis of nevi and initial choroid melanomas with the aid of a diagnostic table]. Vestn Oftalmol (1990) 0.75
[The organ-saving treatment of intraocular tumors (development trends)]. Vestn Oftalmol (2004) 0.75
[Validation of the use of brachytherapy in uveal melanomas of juxtapapillary localization]. Vestn Oftalmol (1992) 0.75
[Role of high-frequency duplex scanning in the differential diagnosis of uveal melanomas and solitary choroidal hemangiomas]. Vestn Oftalmol (2006) 0.75
[Pathogenesis of optic neuropathy in edematous exophthalmos]. Vestn Oftalmol (2009) 0.75
[General activity and isoenzyme spectrum of lactate dehydrogenase in the eye tissue during cryogenic surgery]. Vestn Oftalmol (1980) 0.75
[Results of the treatment of retinoblastoma]. Vestn Oftalmol (1995) 0.75
[Procedure for calculating the volume of the osseous orbit from the data of computed tomography]. Vestn Oftalmol (2009) 0.75
[Venography as 1 method for the differential diagnosis of orbital neoplasms]. Vestn Oftalmol (1972) 0.75
[Diagnostic value of computerized tomography in the posttraumatic surgery of complicated eye injuries]. Vestn Oftalmol (1987) 0.75
[Orbital apex syndrome]. Vestn Oftalmol (1989) 0.75
[Pathogenetic and symptomatic treatment of endocrine ophthalmopathies]. Vestn Oftalmol (1984) 0.75
[Orbitotonometry in the diagnosis of unilateral exophthalmos]. Vestn Oftalmol (1970) 0.75
[Orbital spatula--light guide]. Vestn Oftalmol (1973) 0.75
[The current aspects of the treatment of uveal melanomas]. Vestn Oftalmol (1999) 0.75
[Various aspects of the technic for enucleating the eye in melanomas of the choroid]. Vestn Oftalmol (1983) 0.75
[Current topics of ophthalmic oncology]. Vestn Oftalmol (1997) 0.75
[A method of evaluating the clinical course of edematous exophthalmos and pseudotumor of the orbit]. Vestn Oftalmol (1990) 0.75
[Fluorescence angiography in the diagnosis of pigment-free melanomas of the choroid]. Vestn Oftalmol (2005) 0.75
[Diagnostic possibilities of gamma-topography using 111In-bleomycin in malignant tumors of the orbit]. Med Radiol (Mosk) (1989) 0.75
[Combined and radiation treatments of malignant lacrimal gland tumors]. Med Radiol (Mosk) (1981) 0.75
[The concept of ophthalmologic oncology development]. Vestn Oftalmol (2001) 0.75
[Results of combined radiotherapy of choroid melanomas]. Vestn Oftalmol (2001) 0.75
[Internal orbital decompression in uncompensated edematous exophthalmos]. Vestn Oftalmol (2006) 0.75
[Classification and clinical characteristics of endocrine ophthalmopathy]. Vestn Oftalmol (1983) 0.75
[Clinical and epidemiological study of lacrimal neoplasms]. Vestn Oftalmol (2009) 0.75
[Stereoarteriographic symptoms of meningiomas of the orbit]. Vestn Oftalmol (1977) 0.75
[Ophthalmologic oncology: successes and developmental prospects]. Vestn Oftalmol (1977) 0.75
[Orbitotomy performed with the use of ultrasonic instruments]. Vestn Oftalmol (1975) 0.75
[Surgical correction of diplopia in patients with endocrine myopathy]. Vestn Oftalmol (1985) 0.75
[Molecular diagnosis of retinoblastoma. First experience in Russia]. Vestn Oftalmol (2002) 0.75
[Is differential diagnosis between soft tissue paraneural lesions and optic nerve tumors using computer tomography possible?]. Vestn Oftalmol (2011) 0.75
[Results of organ-preserving treatment in tumors of the iridociliary region and the indications for its use]. Oftalmol Zh (1978) 0.75
[Recent aspects of pathogenesis and treatment of endocrine ophthalmopathy]. Vestn Ross Akad Med Nauk (2003) 0.75
[Spectrum and frequencies of RB1 gene structural defects in retinoblastoma]. Mol Biol (Mosk) (2002) 0.75
[Complications of transpupillary thermotherapy for choroidal melanomas and possibilities for their prevention]. Vestn Oftalmol (2010) 0.75
[Treatment of ciliochoroidal melanomas with a medical narrow proton beam]. Vestn Oftalmol (1986) 0.75
[Relationship of the angiographic symptoms to the clinical morphological characteristics of choroidal tumors]. Vestn Oftalmol (1980) 0.75
[Computer tomography in the diagnosis of intraocular melanomas]. Vestn Oftalmol (1991) 0.75
[A risk of metastasis of choroid melanoma after brachytherapy]. Vestn Oftalmol (2003) 0.75
[Euthyroid Graves' disease (problems of diagnosis and treatment)]. Vestn Oftalmol (2001) 0.75
[Postradiation secondary glaucoma and prevention measures]. Vestn Oftalmol (1992) 0.75